Skip to main content
Premium Trial:

Request an Annual Quote

Yourgene Health Gets Australian Approval for Chemotoxicity Assay

NEW YORK — Yourgene Health said on Friday that it has received approval to sell its Elucigene DPYD chemotoxicity diagnostic assay in Australia.

The genotyping test, which was launched last year, is designed to identify cancer patients with dihydropyrimidine dehydrogenase deficiency, which can result in life-threatening side effects when the patients are treated with the chemotherapeutic agent 5-fluorouracil. 

According to Manchester, UK-based Yourgene, the test will be exclusively sold in Australia by its distribution partner, Southern Cross.

"We are extremely pleased to address another market with our first oncology test, which has already seen traction in the UK and Europe," Yourgene CEO Lyn Rees said in a statement.

Yourgene recently secured a contract for the Elucigene DPYD assay in the UK with a National Health Service trust.

The Scan

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.

Clinical Trial Participants, Investigators Point to Importance of Clinical Trial Results Reporting in Canadian Study

Public reporting on clinical trial results is crucial, according to interviews with clinical trial participants, investigators, and organizers from three provinces appearing in BMJ Open.

Old Order Amish Analysis Highlights Autozygosity, Potential Ties to Blood Measures

Researchers in BMC Genomics see larger and more frequent runs-of-homozygosity in Old Order Amish participants, though only regional autozygosity coincided with two blood-based measures.

Suicidal Ideation-Linked Loci Identified Using Million Veteran Program Data

Researchers in PLOS Genetics identify risk variants within and across ancestry groups with a genome-wide association study involving veterans with or without a history of suicidal ideation.